Cockcroft- Gault) påvirkede ikke tocilizumabs farmakokinetik.
Mild renal impairment (creatinine clearance based on Cockcroft-Gault < 80 ml/ min and ≥ 50 ml/ min) did not impact the pharmacokinetics of tocilizumab.